Dr. Oh Discusses the Utility of Cabazitaxel

William K. Oh, MD, Chief of the Division of Hematology and Medical Oncology, the Tisch Cancer Institute at Mount Sinai Medical Center, discusses the utility of cabazitaxel for prostate cancer.

For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/

• #education
• #targeted_oncology
• #oncology
• #cancer
• #cabazitaxel
• #chemotherapy
• #prostate_cancer_disease_or_medical_condition